Hot Watch List: OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI), PAR Technology Corporation (NYSE:PAR), Kronos Worldwide, Inc. (NYSE:KRO), Amicus Therapeutics, Inc. (NASDAQ:FOLD), Omeros Corporation (NASDAQ:OMER)

OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) announced that it will report its second quarter 2015 financial results on Thursday, August 13, 2015. Company management will host a conference call and live webcast at 4:30 p.m. Eastern Time to provide an overview of financial results, clinical development programs and a general corporate update.OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) belongs to Healthcare sector. Its weekly performance is -11.88%. On last trading day company shares ended up $3.04. OncoGenex Pharmaceuticals, Inc. (NASDAQ:OGXI) distance from 50-day simple moving average (SMA50) is 13.85%.

PAR Technology Corp. (NYSE: PAR) reported net income of $101,000, or 1 cent per share, in the second quarter. That’s compared to a net loss of $519,000, or 3 cents, in the same period in 2014, the company reported Thursday afternoon. PAR Technology Corporation (NYSE:PAR) shares increased 18.31% in last trading session and ended the day at $5.04. PAR Gross Margin is 22.10% and its return on assets is -2.30%. PAR Technology Corporation (NYSE:PAR) quarterly performance is 13.77%.

Kronos Worldwide Inc. (NYSE:KRO) on Friday reported a second-quarter loss of $159.8 million, after reporting a profit in the same period a year earlier. On a per-share basis, the Dallas-based company said it had a loss of $1.38. Losses, adjusted for pretax expenses, came to 8 cents per share. The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of 23 cents per share.On 07 August, Kronos Worldwide, Inc. (NYSE:KRO) shares decreased -1.50% and was closed at $9.82. KRO EPS growth in last 5 year was 34.80%. Kronos Worldwide, Inc. (NYSE:KRO) year to date (YTD) performance is -24.58%.

On 5 August, Amicus Therapeutics, Inc. (NASDAQ:FOLD) reported Net loss was $27.1 million, or $0.27 per share, compared to a net loss of $14.6 million, or $0.22 per share, for the second quarter 2014. Amicus Therapeutics, Inc. (NASDAQ:FOLD) ended the last trading day at $15.19. Company weekly volatility is calculated as 7.50% and price to cash ratio as 11.58. Amicus Therapeutics, Inc. (NASDAQ:FOLD) showed a weekly performance of -11.63%.

Omeros Corporation (NASDAQ:OMER) announced that Gregory A. Demopulos, M.D., chairman and chief executive officer, will present at the 2015 Wedbush PacGrow Healthcare Conference in New York next week. The presentation is scheduled for Tuesday, August 11 at 12:45 pm EDT. Omeros Corporation (NASDAQ:OMER) shares increased 0.47% in last trading session and ended the day at $14.89. OMER Gross Margin is 100.00% and its return on assets is -198.80%. Omeros Corporation (NASDAQ:OMER) quarterly performance is -28.41%.

Leave a Reply

Your email address will not be published. Required fields are marked *